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One of the conventional approaches in tissue engineering is the use of scaffolds in 
combination with cells to obtain mechanically stable tissue constructs in vitro prior to 
implantation. Additive manufacturing by fused deposition modeling is a widely used 
technique to produce porous scaffolds with defined pore network, geometry, and 
therewith defined mechanical properties. Bone marrow-derived mesenchymal stromal 
cells (MSCs) are promising candidates for tissue engineering-based cell therapies due 
to their multipotent character. One of the hurdles to overcome when combining additive 
manufactured scaffolds with MSCs is the resulting heterogeneous cell distribution and 
limited cell proliferation capacity. In this study, we show that the use of a biaxial rotating 
bioreactor, after static culture of human fetal MSCs (hfMSCs) seeded on synthetic poly-
meric scaffolds, improved the homogeneity of cell and extracellular matrix distribution 
and increased the total cell number. Furthermore, we show that the relative mRNA 
expression levels of indicators for stemness and differentiation are not significantly 
changed upon this bioreactor culture, whereas static culture shows variations of several 
indicators for stemness and differentiation. The biaxial rotating bioreactor presented here 
offers a homogeneous distribution of hfMSCs, enabling studies on MSCs fate in additive 
manufactured scaffolds without inducing undesired differentiation.
Keywords: bone marrow stromal cells, scaffolds, biaxial rotating bioreactor, perfusion-flow bioreactor, cellular 
distribution
inTrODUcTiOn
The field of tissue engineering aims at applying the fundamentals of cell biology and materials 
engineering to construct replacements for damaged, diseased, or lost tissue (Langer and Vacanti, 
1993). One of the conventional approaches is based on three-dimensional (3D) mechanically 
stable scaffolds in combination with multipotent cell types. Scaffolds with a highly defined 
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geometry, porosity, and tailored mechanical properties can 
be obtained by additive manufacturing (Moroni et  al., 2005). 
These scaffolds provide the necessary support for cells to attach, 
proliferate, and differentiate, and define the overall shape of 
the tissue engineered transplant. Several researchers already 
showed successful application of such scaffolds in, for example, 
bone and cartilage tissue engineering in vivo (Woodfield et al., 
2004; Kim et al., 2012; Reichert et al., 2012). Woodfield et al. 
found a rapid attachment and a homogenous distribution of 
both bovine and human chondrocytes on poly (ethylene oxide 
terephthalate)-co-poly (butylene terephthalate) (PEOT/PBT) 
based scaffolds after spinner flask culture in vitro. Subsequently, 
scaffolds seeded with bovine chondrocytes were implanted sub-
cutaneously in mice for 21 days and formed cartilaginous tissue 
in vivo as demonstrated by the presence of articular extracellu-
lar matrix (ECM) components (Woodfield et al., 2004). Despite 
successes in regenerating tissues with additive manufactured 
scaffolds optionally combined with different bioreactors, the 
highly organized open structure of such scaffolds poses still 
challenges in homogenously distributing cells and controlling 
their proliferation and differentiation capacities. This is even 
more important when mesenchymal stromal cell (MSCs) are 
used, as their capacity to adhere and be homogeneously distrib-
uted in 3D scaffolds has shown to be more demanding (Griffon 
et al., 2011).
To gain control over cell seeding efficiency, distribution and 
fate on additive manufactured 3D scaffolds in  vitro prior to 
implantation or as a study model, several hurdles have to be 
overcome. First, the cell seeding process has to be optimized 
per scaffold geometry, scaffold material, and cell type to 
achieve proper cell attachment and distribution throughout 
the construct (Sobral et  al., 2011). Several studies showed 
the influence of scaffold geometry or culture conditions in 
cell and tissue distribution after in vitro culture (Wang et al., 
2005; Leferink et  al., 2013). Papadimitropoulos et  al. (2013) 
introduced a collagen-network in porous PCL–TCP scaffolds, 
which resulted in a 2.5-fold increase in MSCs seeding efficiency 
under perfusion flow compared to the bare PCL–TCP scaffolds. 
Despite an increased cell seeding efficiency in the presence of 
a collagen-network, no obvious qualitative differences were 
found after 19 days of culture among the experimental groups 
with respect to cell viability and distribution, and ECM forma-
tion. Although the incorporation of a collagenous matrix in 
additive manufactured scaffolds seemed to have a beneficial 
effect on cell seeding efficiency, control over cell fate remains 
to be further elucidated.
A second hurdle to overcome is the supply of oxygen 
and nutrients as well as the clearance of metabolic products 
which showed to become critically limiting for cells cultured 
under static conditions (Schantz et  al., 2012). Bioreactor 
systems, based on convection, such as rotating vessels and 
stirrer flasks, or based on perfusion, such as a directional 
flow-through bioreactor, are used to overcome these mass 
transfer limitations (Grayson et al., 2011). These systems do 
not only enhance nutrient and waste product exchange but 
can also exert mechanical stimuli on the cells to proliferate, 
migrate, or differentiate (Martin et  al., 2004; Grayson et  al., 
2011). Although most of these commercially available rotating 
vessel bioreactors are uniaxial in design, Singh et  al. (2005) 
have shown with in  silico simulations that a biaxial design, 
which rotates simultaneously in two independent orthogonal 
axes, resulted in improved fluidics over an uniaxial design. 
Therefore, we investigated the use of a biaxial bioreactor 
system for the in  vitro culture of highly porous PEOT/PBT 
scaffolds seeded with human fetal MSCs (hfMSCs) or human 
adult MSCs (haMSCs).
Previous work showed the differentiation potential of 
hfMSCs into the adipogenic (Jo et  al., 2008), osteogenic 
(Guillot et al., 2008; Abarrategi et al., 2012; Brady et al., 2014), 
and chondrogenic (Abarrategi et  al., 2012; van Gool et  al., 
2012) lineages and maintenance of telomerase activity during 
in vitro monolayer culture (Jo et al., 2008). Also for haMSCs, 
multipotency is traditionally shown by studying the differen-
tiation capacity into the adipogenic (Pittenger et  al., 1999), 
chondrogenic (Mackay et al., 1998; Pittenger et al., 1999), and 
osteogenic (Pittenger et al., 1999) lineages in the presence of 
soluble factors in monolayer or pellet culture in vitro. Yet, the 
differentiation of haMSCs into multiple other lineages, such 
as the neurogenic (Zaim et  al., 2012), endothelial (Janeczek 
Portalska et  al., 2012), and myogenic lineages (Muguruma 
et al., 2003; Bossolasco et al., 2004), has been reported as well. 
The multipotent differentiation capacity of haMSCs is donor 
and age dependent and decreases upon increasing population 
doublings in  vitro (Zaim et  al., 2012). Zhang et  al. (2009a) 
reported a superior proliferative and osteogenic differentiation 
capacity of hfMSCs over haMSCs after comparative studies 
in vitro in static monolayer culture. In addition, both hfMSCs 
and haMSCs showed osteogenic differentiation on a composite 
bioactive PCL–TCP scaffold in static culture in vitro and ectopic 
bone formation in the scaffold after implantation in vivo. Yet, 
osteogenic differentiation of hfMSCs was found superior to 
haMSCs.
We hypothesize that by the introduction of a biaxial rotat-
ing bioreactor, higher cell numbers and a more homogeneous 
distribution of cells throughout 3D scaffolds could be achieved 
compared to static culture in a well plate. It is well-known that 
shear forces due to medium flow can affect cell fate. Therefore, 
in this study, the effect of bioreactor culture on cell and ECM 
distribution as well as on cellular phenotype was assessed for 
both hfMSCs and haMSCs cultured on scaffolds in two differ-
ent bioreactor systems and compared to the results from static 
culture on scaffolds in a well plate. In our study, we chose PEOT/
PBT as a biomaterial to fabricate 3D additive manufactured scaf-
folds. This family of copolymers has shown successful applica-
tions in tissue regeneration applications (Beumer et  al., 1994; 
Claase et  al., 2007; Moroni et  al., 2008), due to the flexibility 
to change their physico-chemical and mechanical properties 
(Deschamps et al., 2002). These results in the possibility to con-
trol cell adhesion, morphology, and ultimately phenotype at the 
interface with 3D scaffolds made of these biomaterials, which 
is of particular interest for stem cell-driven tissue regeneration 
strategies.
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MaTerials anD MeThODs
isolation and culture of hfMscs  
and haMscs
Bone marrow-derived hfMSCs were isolated as described before, 
from 17  weeks and 1-day-old fetuses after clinically indicated 
termination of pregnancy (Chan et al., 2007; Zhang et al., 2009b). 
Pregnant women gave separate written consent for the clinical 
procedure and for the use of fetal tissue for research purposes. 
Briefly, fetal bone marrow cells were retrieved by flushing the 
bone marrow cells out of the humeri and femurs into Dulbecco’s 
modified eagle’s medium (DMEM, Sigma, USA) with Glutamax 
(GIBCO, USA) supplemented with 10% heat-inactivated fetal 
bovine serum (FBS, Hyclone, USA), 50  U/mL penicillin, and 
50 μg/mL streptomycin (GIBCO, USA), which will be referred 
to as fMSC medium. Medium was refreshed twice per week and 
cells were used for further subculturing or cryopreservation on 
reaching near confluence.
Bone marrow-derived haMSCs (donor 1 female, 77  years 
old; donor 2 female, 55 years old) were isolated and proliferated, 
as described previously (de Bruijn et  al., 1999). Bone marrow 
aspirates were obtained from patients who had given written 
informed consent. Briefly, aspirates were cultured in minimal 
essential medium (alpha-MEM; Life Technologies, USA) sup-
plemented with 10% heat-inactivated fetal bovine serum (FBS; 
Lonza, USA), 0.2 mM l-Ascorbic acid 2-phosphate magnesium 
salt (ASAP, Sigma-Aldrich, the Netherlands), 2 mM l-glutamine 
(l-glut, Invitrogen, the Netherlands), 100 U/mL penicillin (Life 
Technologies, USA), 100 μg/mL streptomycin (Life Technologies, 
USA), and 1  ng/mL basic fibroblast growth factor (bFGF; 
Instruchemie, The Netherlands), which will be referred to as 
proliferation medium. Cells were cultured at 37°C in a humidified 
atmosphere with 5% CO2. Medium was refreshed twice per week 
and cells were used for further subculturing or cryopreservation 
on reaching near confluence.
Fabrication of PeOT/PBT scaffolds
Scaffold were fabricated of PolyActive™ 300/55/45 (PolyVation, 
the Netherlands), a block copolymer is composed of poly(ethylene 
oxide terephthalate) (PEOT) and poly(butylene terephthalate) 
(PBT) with a weight ratio of 55:45 for the two components, 
respectively, and a molecular weight of the starting poly(ethylene 
glycol) (PEG) segments of 300 Da used in the co-polymerization 
process (Deschamps et  al., 2002). Fused deposition modeling 
was used with a bioscaffolder (SysENG, Germany) to fabricate 
3D cylindrical scaffolds as described before (Moroni et al., 2005), 
with a diameter of 8 mm and a height of 3 mm. For the additive 
manufacturing process, the fiber spacing was set to 1000 μm, the 
layer thickness to 150 μm, and a needle with an internal diameter 
of approximately 250 μm was used, which resulted in fiber diam-
eters of approximately 200 μm. Scaffolds were treated in Argon 
plasma for 30 min with a pressure of 0.1–0.2 mBar and a power of 
30 W. Sterilization of all scaffolds was performed in 70% ethanol 
twice for 30  min, subsequently washed in PBS first for 5  min 
and additionally twice for another 30 min each time, and finally 
incubated in culture medium overnight prior to cell culture.
cell seeding on PeOT/PBT scaffolds
For studies with hfMSCs, scaffolds were transferred from a tube 
with culture medium to a non-treated 24-well plate (Greiner bio-
one, Germany). Passage 3 hfMSCs were harvested from monolayer 
expansion, and seeded on the scaffolds with a density of 750,000 
cells in 30 μL of fMSC medium. After 15 min of incubation, the 
scaffolds were flipped and allowed to incubate for another 45 min 
before 10 μL of fMSC medium was added. Subsequently, for the 
next 5 h, 10 μL of proliferation medium was added for each seeded 
scaffolds at an interval of 75 min for each addition. Scaffolds were 
then transferred to a non-treated 24-well plate (Greiner bio-one, 
Germany) with 750 μL of proliferation medium and cultured for 
3 days either in static culture conditions or in a biaxial rotating 
vessel bioreactor for which the culture parameters are specified 
in the next section.
For studies with haMSCs, scaffolds were transferred from a 
tube with culture medium to a non-treated 24-well plate (NUNC, 
Fisher Scientific, the Netherlands). Passage 3 haMSCs were har-
vested from monolayer expansion, and seeded on the scaffolds 
with a density of 750,000 cells in 100 μL of proliferation medium. 
After 1.5 h incubation, the medium was filled up to 1 mL and cell 
culture was continued for 3 days in static culture condition before 
transferring the samples to a new culture well, to the biaxial bio-
reactor system, or to a bioreactor perfusion culture. The culture 
parameters in the bioreactors are specified in the next section.
In the results section, the legends of the figures refer to the 
total culture time, including the static incubation period on the 
scaffolds placed in a well plate (in most figures this period was 
3 days, unless specified differently).
Bioreactor culture
After static culture, some of the scaffolds were transferred to 
the biaxial bioreactor system or the chamber of the perfusion 
bioreactor, whereas a control group was maintained under static 
culture conditions (Figure 1). The perfusion bioreactor consisted 
of a small chamber in which the scaffold was press-fitted to ensure 
the medium to be flown through the longitudinal pores of the 
scaffold. The set-up of the perfusion bioreactor was constructed, 
as described before (Janssen et al., 2006). Medium was ran with a 
flow speed of 0.1 mL/min in a home-made incubator at 37°C with 
a controlled flow of mixed gas containing 5% CO2 and 21% O2.
The biaxial bioreactor system consisted of a cylindrical ves-
sel for culture (volume 40  mL), in which the cellular-scaffold 
constructs are mounted to the lid of the bioreactor by pins, and 
a medium reservoir to ensure continuous replacement of the 
medium in the culture vessel. Gaseous exchange was enabled 
through a special membrane incorporated into the medium 
reservoir. The bioreactor was ran with a medium flow speed of 
1 rpm (corresponding to 1.5 mL/min), a biaxial rotation with an 
arm rotational speed of 2 rpm, and a chamber rotation speed of 
3 rpm at 37°C in a humidified atmosphere with 5% CO2.
Proliferation medium was used to fill the 40  mL medium 
reservoir of the perfusion bioreactor containing 1 scaffold seeded 
with haMSCs per circuitry. Proliferation medium was used to fill 
the 40 mL bioreactor chamber and the 300 mL reservoir of the 
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biaxial bioreactor containing 4 scaffolds seeded with haMSCs. 
fMSC medium was used to fill the 500 mL bioreactor chamber 
and the 300 mL reservoir of the biaxial bioreactor containing 12 
scaffolds seeded with hfMSCs. As a control, static culture was 
continued on the scaffolds that were transferred to a new well in 
a non-treated 24-well plate.
Viability staining
Cell viability was assessed by 4  μg/mL fluorescein diacetate 
(FDA, Sigma-Aldrich, the Netherlands) and 40 μg/mL propidium 
iodide (PI, Sigma-Aldrich, the Netherlands) staining, where FDA 
stains viable cells green, and PI stains necrotic and apoptotic cell 
nuclei red. Scaffolds were cut in half, stained with FDA and PI, 
as previously described (Zhang et al., 2009a), and viewed under 
a confocal laser microscope (Olympus, FV1000Fluoview, Japan). 
Cellular scaffolds were examined in both planar view and cross-
sectional view after 3 and 9 days of culture.
Dna assay
The total DNA from scaffolds cultured with hfMSCs was 
extracted from each scaffold by incubating the constructs in 
0.4 mL of enzymatic cocktail [consisting of 0.1% collagenase A 
FigUre 1 | a schematic representation of the bioreactor set-ups. (a) hMSCs were cultured at 37°C in a humidified atmosphere with 5% CO2 in culture flasks 
to allow them to proliferate. After expansion, the cells were trypsinized from monolayer culture and seeded onto 3D additive manufactured scaffolds (B), or stored 
for analysis of the basal gene expression levels (day 0). (e) Seeded scaffolds were statically incubated for 90 min or 6 h in a 24-well plate to allow the hMSCs to 
adhere to the 3D scaffold before filling the well with culture medium. After several days of incubation, the scaffolds were transferred to a small press-fit chamber in 
the perfusion bioreactor (D) or in the vessel of the biaxial rotating bioreactor (c) in which culture was prolonged for several days before analyses.
(Roche, Switzerland) with 0.1% Trypsin mixed in PBS] at 37°C 
for 2 h, with vortex every 30 min followed by three cycles of freeze 
and thaw. For haMSCs, after culture all scaffolds were washed 
gently in PBS, dried by aspirating the PBS, cut in pieces and 
stored at −80°C for at least 24 h. After thawing, the constructs 
were digested for 16 h at 56°C with 1 mg/mL proteinase K (Sigma-
Aldrich, the Netherlands) in Tris/EDTA buffer (pH 7.6). This 
solution contained 18.5 μg/mL iodoacetamine (Sigma-Aldrich, 
the Netherlands) and 1 μg/mL Pepstatin A (Sigma-Aldrich, the 
Netherlands). Quantification of total DNA was done using the 
CyQuant® DNA assay (Molecular Probes, Fisher Scientific, the 
Netherlands) and a spectrophotometer (excitation 480 nm, emis-
sion 520 nm) (Victor 3, Perkin Elmer, the Netherlands).
hydroxyproline assay
Hydroxyproline colorimetric assay kit (Biovision, USA) was 
performed according to the manufacturer’s protocol to determine 
the total collagen amount on the same samples as used for DNA 
quantification. In brief, from the digested sample, 30  μL was 
transferred to a Teflon® capped glass bottle. Another 30 μL of 
concentrated hydrochloric acid (HCl, 12M, Sigma-Aldrich, the 
Netherlands) was added and samples were hydrolyzed at 120°C 
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for 3 h. The complete supernatant was transferred to a 96-well 
plate and left to evaporate at 60°C. Subsequently, 100 μL of chlo-
ramine T/Oxidation buffer mix (Biovision, USA) was added to 
each well and incubated at room temperature for 5 min. Finally, 
100 μL of DMAB Reagent (Biovision, USA) was added to each 
well including the hydroxyproline standard and incubated for 
90 min at 60°C. A micro plate reader (Multiskan GO, Thermo 
Fisher, the Netherlands) was used to determine the absorbance 
at 560 nm.
gene expression analysis of hfMscs  
and haMscs
For gene expression analysis of hfMSCs, samples were seeded 
(n = 4 for static cultures; n = 5 for the biaxial bioreactor system) 
at different time points. After culture, medium was aspirated from 
the scaffolds, the samples were transferred to 2  mL Eppendorf 
tubes and stored at −80°C. Prior to RNA isolation from the 
samples by using a Bioke RNA II nucleospin RNA isolation kit 
(Macherey-Nagel, Germany), first 500 μL of TRIzol® (Invitrogen, 
the Netherlands) was added. The scaffolds were disrupted by 
crushing with RNA isolation pestles (Kimble Kontes, Fisher 
Scientific, the Netherlands). Samples for basal gene expression 
analysis, referred to as T25 day 0, were retrieved from two-
dimensional (2D) culture in T25 tissue culture flasks (NUNC, 
Fisher Scientific, the Netherlands) by adding 500 μL of TRIzol® 
(Invitrogen, the Netherlands) upon reaching 70% confluence. 
Subsequently, the cell/TRIzol® suspension was transferred to an 
Eppendorf tube and 200 μL of CHCl3 was added to each sample 
and mixed by vigorously shaking the tubes. The TRIzol®/CHCl3 
mixture was centrifuged at 12,000 ×  g for 15  min at 4°C. The 
aqueous phase was transferred to a new Eppendorf tube and 
mixed 1:1 with 70% ethanol. The mixture was transferred to 
filter columns from the kit and the RNA isolation was continued 
following the manufacturer’s protocol. RNA concentrations and 
purity were determined by using an ND1000 spectrophotometer 
(Nanodrop Technologies, USA). The cDNA was synthesized from 
630 ng of RNA, using iScript™ (BIO-RAD, Bio-rad Laboratories, 
the Netherlands) according to the manufacturer’s protocol. 
Quantitative polymerase chain reaction (qPCR) was performed 
on cDNA samples by using the iQ SYBR® Green Supermix (Bio-
Rad, the Netherlands) on the primers as listed in Table 1. PCR 
reactions were carried out on the MyiQ2 Two-Color Real-Time 
PCR Detection System (Bio-Rad, the Netherlands) under the 
following conditions: cDNA was denatured for 10 min at 95°C, 
followed by 40 cycles, consisting of 15 s at 95°C, 30 s at 60°C, and 
30 s at 72°C. For each reaction, a melting curve was generated 
to test primer dimer formation and non-specific priming. The 
cycle threshold (Ct) values were determined with the Bio-RadiQ5 
optical system software, in which a threshold value was set for the 
fluorescent signal at the lower log-linear part above the baseline. 
Ct values were normalized to the B2M housekeeping gene and 
ΔCt ((average of Ctcontrol) − Ctvalue). Results are expressed as rela-
tive mRNA expression normalized to the gene expression levels 
of hfMSCs from T25 day 0 and calculated as 2−ΔCt.
For gene expression analysis of haMSCs, samples were 
seeded statically for 3 days followed by another 6 days of static 
culture or 6 days of dynamic culture in the biaxial bioreactor 
system or in the perfusion-flow bioreactor. After culture, 
medium was aspirated from the scaffolds, the samples were 
transferred to 2  mL Eppendorf tubes and stored at −80°C. 
Samples for basal gene expression analysis (referred to as day 
0 static culture) were retrieved from 2D culture in T25 tissue 
culture asks (NUNC, Fisher Scientific, the Netherlands) by 
adding 500 μL of TRIzol® (Invitrogen, the Netherlands) upon 
reaching 70% confluence. RNA isolation, cDNA synthesis, and 
RT-PCR were carried out as described for hfMSCs. Results are 
expressed as relative mRNA expression normalized to the gene 
expression levels of haMSCs from T25 day 0 and calculated 
as 2−ΔCt.
scanning electron Microscopy analysis
Cell morphology, attachment, and distribution were character-
ized by scanning electron microscopy (SEM) analysis with a 
Philips XL 30 ESEM-FEG (FEI, the Netherlands). Samples were 
fixed for 30 min in 10% formalin. Subsequently, the samples were 
dehydrated in sequential ethanol series and critical point dried 
from liquid carbon dioxide using a Balzers CPD 030 Critical 
Point Dryer (Leica, Germany). The constructs were gold sputter 
coated (Cressington, UK) prior to SEM analysis. SEM images 
were obtained under high vacuum with an acceleration voltage 
of 30 kV and a working distance of 10 mm.
Methylene Blue staining
Cell morphology, attachment, and distribution of haMSCs 
were qualitatively assessed by methylene blue staining. Samples 
were fixed for 30 min in 10% formalin, washed with PBS twice, 
and stained with methylene blue (Sigma, the Netherlands) 
for 30  s immediately followed by extensive washing with 
DI-water until the water remained colorless. The samples 
were imaged using a stereomicroscope (Nikon SMZ800 with 
Q-imaging Retiga 1300 camera, Nikon Instruments Europe, 
the Netherlands).
histological analysis
Samples were fixed after live/dead imaging or directly after cul-
ture for 30 min in 10% formalin and stored in PBS at 5°C until 
further processing. Samples were dehydrated using a sequential 
ethanol series (60, 70, 80, 90, 96, and 100% ethanol, 30 min for 
each step), and subsequently embedded in glycol methacrylate 
(GMA). The obtained blocks were sectioned at 5 μm intervals, 
and stained with hematoxylin and eosin (H&E, Sigma, the 
Netherlands) for visualization of the nuclei and cytoplasm, and 
Masson Trichrome (Merck, Germany) to stain for collagen-like 
ECM formation.
statistical analyses
Results are presented as mean ± SD, and compared using either 
one-way ANOVA (multiple conditions) with a Bonferroni post-
test or Student’s t-test (two conditions). Statistical significance 
was set to p-value <0.05 (*).
TaBle 1 | Primer sequences.
gene Forward primer reverse primer
B2M GACTTGTCTTTCAGCAAGGA ACAAAGTCACATGGTTCACA
ALCAM ACGATGAGGCAGACGAGATAAGT CAGCAAGGAGGAGACCAACAA
CD-63 GCCCTTGGAATTGCTTTTGTCG CATCACCTCGTAGCCACTTCT
f-Actin GGCATCCTCACCCTGAAGTA GGTGTGGTGCCAGATTTTC
Runx2 GGAGTGGACGAGGCAAGAGTTT AGCTTCTGTCTGTGCCTTCTGG
ALP ACAAGCACTCCCACTTCATC TTCAGCTCGTACTGCATGTC
ACAN AGGCAGCGTGATCCTTACC GGCCTCTCCAGTCTCATTCTC
Sox9 TGGGCAAGCTCTGGAGACTTC ATCCGGGTGGTCCTTCTTGTG
Col-1 GTCACCCACCGACCAAGAAACC AAGTCCAGGCTGTCCAGGGATG
Col-2 CGTCCAGATGACCTTCCTACG TGAGCAGGGCCTTCTTGAG
FigUre 2 | live/dead staining showed a high cell viability of fetal hMscs after 9 days of static culture in a well plate (a,B) and after 3 days of culture 
in static condition in a plate followed by 6 days of culture in a biaxial bioreactor (c,D). Higher numbers of cells were found in the scaffolds after culture in 
the biaxial bioreactor compared to the scaffolds from static culture. This was confirmed by DNA quantification (e) where a significant difference in cell number was 
found between static culture in a plate and culture in the biaxial bioreactor. DNA quantification also shows a significance increase in cell number in time (90 min, 3, 
9 days) when the cells are cultured statically in a well plate. (F) Collagen production per cell did not increase in time and significantly decreased upon culture in the 
biaxial bioreactor compared to 1 day of static culture subsequent to 90 min of seeding in a concentrated suspension and to 3 days of static culture [90 min and 6 h 
(n = 5), day 3 (n = 10), day 9 static (n = 12), day 9 biaxial bioreactor (n = 14), *p < 0.05, **p < 0.01, ***p < 0.001].
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resUlTs
Viability, Distribution, and gene 
expression Profile of hfMscs
Scaffolds seeded with hfMSCs showed comparable viability after 
9 days of culture in both well plate (static) and in the biaxial biore-
actor (Figures 2A,C, respectively). A high viability was also found 
6 h after seeding (Figures S1A,B in Supplementary Material) and 
after 3  days of static culture (Figures  S1C,D in Supplementary 
Material). In the cross-sectional view of the scaffolds, it could 
be observed that the number of hfMSCs and their distribution 
seemed to be enhanced when the constructs were cultured in the 
biaxial bioreactor (Figure  2D) compared to the scaffolds with 
hfMSCs cultured statically in a well plate (Figure 2B). Also, the 
morphology of the cells in the pores of the scaffolds appeared 
more spread after culture in the biaxial bioreactor (Figures S1E–H 
in Supplementary Material). The difference in cell number was 
confirmed by DNA quantification (Figure 2E). Both the scaffolds 
in static culture and in the biaxial bioreactor showed an increase 
in cell number over time; yet, the increase in the biaxial bioreactor 
was significantly higher than in static culture.
Furthermore, allowing the cells to adhere to the scaffold 
initially for 6 h before adding medium resulted in a significant 
higher cell seeding efficiency than when the medium was added 
already after 1.5 h of incubation. A hydroxyproline assay was per-
formed to determine the total amount of intra and extracellular 
collagen, which is a measure for cells activity and ECM formation 
(Figure 2F). A small increase in total collagen production per cell 
was observed between 6 h and 3 days of static culture, whereas 
the DNA content remained similar. At later timepoints, the DNA 
content increased, whereas the total collagen content per scaffold 
remained constant for these conditions, resulting in a decrease 
of collagen production per cell. This suggests that hfMSCs were 
mainly proliferating.
Gene expression levels of ALCAM (CD166, activated 
leukocyte cell adhesion molecule) and CD63, both indicators 
for stemness (Jeannet et al., 2013) (Figures 3A,B respectively), 
fluctuated over time in static culture. ALCAM and CD63 were 
FigUre 3 | relative mrna expression levels were assessed by qPcr. The basal mRNA expression levels were determined for hfMSCs from monolayer 
culture on tissue culture-treated polystyrene (Day 0). (a,B) ALCAM and CD63, both genes associated with the maintenance of stemness, did not show significant 
differences between the basal gene expression levels and the expression levels after 9 days of static or biaxial bioreactor culture. (c) F-Actin showed a slight 
down-regulation after 9 days in static culture and a significant up-regulation after 3 days static followed by 6 days biaxial bioreactor culture. This same trend was 
found for Runx2 (i). (g) ALP was down-regulated for both static and biaxial bioreactor culture. (h,D) ACAN and Sox9 were down-regulated in convection culture. 
(e,F) Col-1 and col-2, markers for ECM production, were down-regulated in time in static culture, but retained basal expression levels when the scaffolds were 
placed in biaxial bioreactor culture [n = 4 except for day 9 dynamic (n = 5), *p < 0.05, **p < 0.01, ***p < 0.001].
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similarly expressed after 9  days in both static cultures in a 
well plate and after 9 days of culture in the biaxial bioreactor 
compared to their basal level measured in cells trypsinized 
from monolayer culture at a confluence of approximately 70% 
(day 0 static). F-actin mRNA expression showed a significant 
twofold up-regulation in dynamic culture and a twofold 
down-regulation in static culture after 9  days. A similar but 
less robust trend was found for Runt-related transcription 
factor 2 (Runx2), associated with early osteogenic differen-
tiation. Alkaline phosphatase (ALP) expression, involved in 
osteogenesis, was down-regulated over time both for static and 
bioreactor culture.
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Aggrecan (ACAN), a marker for chondrogenesis, did not 
show any significant differences between any of the conditions. 
Yet, Sox9, an early marker for chondrogenesis, was up-regulated 
in static culture in a well plate, whereas the biaxial bioreactor 
system restored the mRNA expression levels similar to the basal 
levels (day 0 static culture). Collagen type-1 (col-1) and collagen 
type-2 (col-2) markers for ECM proteins, abundantly present 
in bone and cartilage, respectively, were both down-regulated 
over time in static culture, whereas their expression levels were 
restored upon culture in the biaxial bioreactor system.
Scanning electron microscopy analysis was performed on 
cross-sections of the scaffolds after 9 days of culture to assess 
cell distribution, morphology, and tissue formation (Figure 4). 
Statically cultured scaffolds (Figures 4A,C,E) showed lower cell 
numbers compared to scaffolds cultured in the biaxial bioreac-
tor (Figures 4B,D,F). The cellular distribution appeared more 
homogeneous and the cells invaded the longitudinal pores of 
the scaffold more profoundly after culture in the biaxial bio-
reactor system compared to culture in static conditions. There 
were no large differences observed in ECM formation and cell 
morphology between static culture and culture in the biaxial 
bioreactor system. In both conditions, the cells were spread 
while partly attached to the scaffold material or the secreted 
ECM. The formed tissue appeared relatively open inside the 
pores of the scaffolds, whereas the outer layer of tissue found 
at the bottom or top of the scaffold appeared as a more dense 
and closed layer.
From the SEM analysis after 6  h (Figures  S2A–C in 
Supplementary Material) and 3  days of static culture 
(Figures S2D–F in Supplementary Material), it could be seen that 
the cell morphology changed over time from a rounded shape 
to a more spread morphology. Similar cell-shape changes were 
observed in 2D culture where hfMSCs showed a more spread 
morphology upon attachment to the substrate material. This 
change in cellular morphology could also be observed in histo-
logical analysis by H&E staining (Figure S3 in Supplementary 
Material). Further analysis with Masson Trichrome staining 
showed collagen-like materials stained green, which did not 
show any differences between 9 days of static culture in a well 
plate and 9 days of culture in the biaxial bioreactor (Figure S4 in 
Supplementary Material).
The cell adherence, Distribution, and 
gene expression Profile of haMscs
Comparing the methylene blue staining of haMSCs after 
3 days of static culture followed by 6 days of culture in a biaxial 
bioreactor (Figure S5B in Supplementary Material) to the stain-
ing after 9  days of static culture in a well plate (Figure S5A in 
Supplementary Material), no improvement on cell number and 
cellular distribution was found upon bioreactor culture. In static 
culture, haMSCs adhered to the fibers and partly filled the pores 
of the scaffold probably upon proliferation and ECM production 
(Figure S5A in Supplementary Material). In the biaxial bioreactor 
culture, the cells did not fill the pores of the scaffold to the same 
extend as the cells in static culture. From the cross-sectional view, 
it could be observed that the distribution of the cells throughout 
the scaffold was still limited in both conditions. Donor 2 showed 
limited cell adherence after 3 days of static culture in a well plate 
followed by 6 days of culture in the perfusion bioreactor (Figure 
S5C in Supplementary Material).
The DNA content was quantified for two donors in triplicate 
(Figure S6 in Supplementary Material). The results showed on 
average a relatively low DNA content (about a threefold less 
compared to hfMSCs) in both bioreactors. For donor 1, a slight 
increase in DNA content was found upon bioreactor culture com-
pared to static culture. Donor 2, however, showed a significant 
difference between static and perfusion culture, and between the 
biaxial bioreactor and the perfusion bioreactor culture. For this 
same donor, higher cell numbers were also observed in static 
culture compared to culture in the biaxial bioreactor or in the 
perfusion bioreactor when the constructs were cultured statically 
in a well plate for 31 days prior to a 14 days culture in the two 
bioreactor systems (Figure S7 in Supplementary Material). These 
findings were confirmed by DNA assay in which a significant drop 
in DNA content was observed after the scaffolds were cultured in 
the biaxial bioreactor or perfusion bioreactor culture compared 
to the DNA content after 31 and 45 days of static culture (Figure 
S8 in Supplementary Material).
The gene expression profile of haMSCs was assessed for the 
same genes as hfMSCs (Figure  5). The gene expression levels 
were determined after 9 days of static culture and compared to 
gene expression levels of haMSCs after 3 days of static culture fol-
lowed by 6 days of dynamic culture in the biaxial bioreactor or in 
the perfusion bioreactor. A significant twofold down-regulation 
of ALCAM was found for haMSCs cultured in a perfusion 
bioreactor compared to static culture and culture in the biaxial 
bioreactor. F-Actin, col-1, and col-2 showed a significant down-
regulation in both dynamic culture systems compared to static 
culture. Sox-9 was significantly down-regulated in the biaxial 
bioreactor and ACAN was up-regulated a 10-fold in perfusion 
culture compared to static culture. However, this change was not 
statistically significant.
DiscUssiOn
Mesenchymal stromal cells derived from bone marrow have been 
used as a cellular source in several tissue engineering applica-
tions due to their availability, ease of isolation from autologous 
source and therewith reduced immunological-related risks upon 
re-implantation. Moreover, MSCs have shown a certain degree of 
plasticity by the ability to differentiate and transdifferentiate after 
differentiation into several well-defined cell lineages both in vitro 
and in vivo (Phinney et  al., 1999; Grove et  al., 2004; Song and 
Tuan, 2004; Phinney, 2007; Russell et al., 2010; Ullah et al., 2013).
The multipotency of MSCs is often assessed by soluble factor-
induced differentiation in which the results of histological or 
biochemical assays are used to characterize cell fate. However, 
instead of focusing on changes in MSCs phenotype by quantify-
ing the expression of differentiation-related genes, it could be also 
of interest to assess to what extent the cellular phenotype of MSCs 
can be maintained by investigating genes related to multipotency. 
FigUre 4 | scanning electron microscopy images of the distribution of hfMscs throughout the scaffolds after 9 days of static culture in a well plate 
(a,c,e) and after 3 days of static followed by 6 days of dynamic culture in a biaxial rotating bioreactor (B,D,F). A slightly more homogeneous distribution 
of cells and ECM was found after culture in the biaxial bioreactor compared to static culture in a well plate. Scale bars represent (a,B) 1 mm, (c,D) 500 μm, and 
(e,F) 50 μm.
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In the past decades, researchers focused on defining stemness and 
identifying stemness markers to be able to more directly assess 
the potency of patient-derived MSC populations (Menicanin 
et al., 2009).
A known drawback in the use of haMSC is their slow prolif-
eration time and generally limited proliferation capacity. More 
recently, hfMSCs have been characterized showing a higher 
proliferation and osteogenic differentiation capacity and reduced 
immunogenicity when compared to mesenchymal stem cell 
populations derived from the umbilical cord, adult adipose tissue, 
or adult bone marrow in 3D culture systems both in vitro and 
in vivo (Zhang et al., 2009a). Here, we have assessed hfMSCs and 
haMSCs behavior in 3D scaffolds with respect to cell attachment, 
proliferation, and genetic profile.
Static and bioreactor culture conditions both resulted in 
similar cell viability on the PEOT/PBT scaffolds (Figures 2A–D). 
However, the number of hfMSCs in the biaxial bioreactor culture 
was higher (Figure 2E) and the distribution of the cells throughout 
the scaffolds seemed to be improved with respect to the scaffolds 
in static culture in a well plate (Figures 2A–D and Figure 4). With 
respect to the gene expression levels, it could be concluded that 
6 days of biaxial bioreactor culture subsequent to 3 days of static 
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culture restored the basal gene expression levels, found at day 0 
in static monolayer culture, for all genes except ALP and f-actin. 
Similar results were found by a study of Katayama et al. (2013), in 
which no change in gene expression levels of stem cell markers, 
such as ALCAM, was found in adult hMSCs cultured on collagen 
sheets under perfusion flow.
FigUre 5 | relative mrna expression levels of haMscs in static, biaxial bioreactor, and perfusion bioreactor culture were assessed by qPcr.  
(a) ALCAM showed a twofold significant down-regulation after 9 days of perfusion culture compared to static and biaxial bioreactor cultures. (B) CD63 showed no 
significant differences between the different culture systems. (c) F-Actin showed a down-regulation after 9 days in both dynamic culture systems compared to static 
culture. (D) Sox9 was significantly up-regulated in static culture in a well plate, whereas the bioreactor systems restored the mRNA expression levels similar to the 
basal levels (day 0 static culture). (e,F) Col-1 and Col-2, markers for extra-cellular matrix production, were down-regulated in both dynamic culture systems.  
(g) ALP showed a significant down-regulation in all conditions after 9 days of culture compared to day 0 in static culture.  (h) ACAN showed a 10-fold up-regulation 
after perfusion culture compared to static and biaxial bioreactor culture; however, this change was not statistically significant. (i) For Runx2, no significant differences 
between the different culture conditions were found (n = 3, *p < 0.05, **p < 0.01, ***p < 0.001).
Considering the genes involved in ECM production, such 
as f-actin, col-1, and col-2, static culture seemed to provide 
insufficient cues to the cells to activate ECM formation-related 
pathways. Col-1 and col-2 expressions were maintained in the 
biaxial bioreactor culture and down-regulated in static culture. 
This indicated that the hfMSCs in the biaxial bioreactor probably 
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experienced shear forces, due to a sort of convection flow, result-
ing in activation of the f-actin pathway among others, which 
could subsequently lead to an increase in tissue formation 
(Sansores-Garcia et  al., 2011). Furthermore, shear forces have 
been known to induce osteogenic differentiation, which could 
explain the initial significant decrease of ALP expression in static 
culture and the subsequent small increase in ALP in the biaxial 
bioreactor (Figure 3) (Yeatts et al., 2012). On the other hand, a 
recent study of Kock et al. (2014) has shown a negative influence 
of perfusion flow on cartilage-like ECM production of chondro-
genic pre-differentiated hMSCs, although these changes were not 
evident from gene expression analysis (Kock et al., 2014).
Scanning electron microscopy analysis (Figures 4E,F) showed 
an increase in tissue formation and tissue density was observed 
for dynamically cultured samples compared to statically cultured 
scaffolds. Although 6 days of culture in the biaxial bioreactor may 
have altered the gene expression levels compared to static culture, 
no difference was found on total collagen production by bio-
chemical and histological analysis (Figure 2F and Figures S4E–H 
in Supplementary Material, respectively). However, the number 
of cells in the interior of the scaffold in the biaxial bioreactor was 
higher than in static culture conditions, indicating that bioreactor 
culture did improve cellular distribution.
Although hfMSCs have shown some beneficial properties over 
haMSCs in previous studies, the application of haMSCs remained 
of interest due to their more immediate clinical relevance. Fetal 
MSCs cannot be used from autologous source and their use 
involves more ethical issues. Therefore, the use of haMSCs on 
these scaffolds in the biaxial bioreactor was evaluated as well. A 
perfusion-flow bioreactor was introduced in parallel to be able to 
compare the results obtained in the biaxial bioreactor culture to 
both static and perfusion culture conditions. The cell number of 
haMSCs per scaffold assessed by DNA assay after 9 days of static 
culture was found to be significantly lower for both haMSC donors 
(Figure S6 in Supplementary Material) compared to  hfMSCs 
(Figure 2E). Cell seeding efficiency of haMSCs has already shown 
to be limited and donor dependent in one of our previous studies, 
in which several seeding parameters were optimized to decrease 
cell loss after seeding (Leferink et al., 2013).
For the two haMSCs donors, no difference in the number of 
cells was found upon culture in the biaxial bioreactor compared 
to static culture conditions. Similar results were found in a study 
of Stiehler et al. (2009), in which hMSCs seeded on PLGA-based 
scaffolds did not show any difference in cell number after 7 days 
of convection culture compared to static culture. In other stud-
ies, perfusion culture was applied on porous 3D scaffolds and 
showed to improve cell proliferation and scaffold colonization 
(Alvarez-Barreto et al., 2007; Bjerre et al., 2008; Grayson et al., 
2008, 2011; Schumacher et  al., 2010). In our study, however, 
perfusion culture showed to significantly decrease the number of 
haMSCs from donor 2 compared to static culture or culture in the 
biaxial bioreactor. This could be due to the highly interconnected 
and organized pore network of additive manufactured scaffolds 
compared to more conventional sponges and non-woven scaf-
folds with random fiber organization used in previous studies. 
A similar negative effect was reported in a study by Bjerre et al. 
(2011) in which perfusion culture unfavorably changed the mor-
phology and vitality of haMSCs (Bjerre et al., 2011).
Differences in initial cell attachment between the two donors 
could be an effect of differences in heterogeneity of cell popula-
tions due to donor variation (DiGirolamo et al., 1999; Phinney 
et  al., 1999; Siddappa et  al., 2007; Leferink et  al., 2013; Siegel 
et  al., 2013). Changes in cell response to the introduction of 
perfusion flow could also be related to several other factors such 
as the amount of ECM produced at the moment of transfer from 
static culture to the perfusion-flow system and the distribution 
of the cells and ECM throughout the scaffold. Upon closure of 
the longitudinal pores of the scaffold due to the presence of the 
formed ECM in static culture, the pressure, or the perfusion flow 
is expected to be increased, which could have led to tissue detach-
ment. We hypothesized that prolonging the static culture period 
prior to applying bioreactor culture could result in more ECM 
with stronger binding and entanglement to the scaffold material 
(Griffon et al., 2011). Therefore, the scaffolds were cultured stati-
cally for 31 days followed by 14 days of culture in the biaxial bio-
reactor or in the perfusion bioreactor. From cross-sectional views 
on methylene blue stained scaffolds (Figure S7 in Supplementary 
Material), it could be observed that the cells and tissues indeed 
seemed to be detached from the scaffold upon dynamic culture, 
whereas in static conditions, a homogeneous distribution of cells 
and tissue throughout the scaffold was found. These results were 
confirmed by DNA quantification, which showed a significant 
loss of cells upon transferring the constructs from static to bio-
reactor culture (Figure S8 in Supplementary Material). In both 
the biaxial bioreactor and the perfusion bioreactor, loosened cell 
sheets were found in the longitudinal pores of the scaffolds. A 
difference between the two bioreactor systems was found with 
respect to the adherence sites of the cells. In perfusion culture 
conditions, cells were found on the outer layer of scaffold mate-
rial, whereas in the biaxial bioreactor, lesser cells were found to 
reside on the outer layer of the scaffold.
The gene expression levels of f-actin, col-1, and col-2 previ-
ously showed to be significantly up-regulated in hfMSCs, whereas 
a significant down-regulation was found in haMSCs when 
comparing the basal gene expression levels and the levels after 
9 days of static culture to the levels after 3 days of static culture 
followed by 6 days of culture in the biaxial bioreactor. For Sox-9, 
a similar response was found for hfMSCs compared to haMSCs. 
ALCAM, CD63, and ACAN did not show any significant differ-
ences in hfMSCs and haMSCs cultured statically or dynamically 
in the biaxial bioreactor. Larger differences in gene expression 
levels were found between perfusion culture and static culture 
than between culture in the biaxial bioreactor and static culture. 
ALCAM, f-Actin, col-1, and col-2 were significantly down-
regulated in perfusion culture compared to static culture after 
9 days. This could have been related to the lower cell number as 
a consequence of relatively high shear forces involved in a perfu-
sion culture system.
Overall, the results presented in this study suggested that a 
more homogeneous cell distribution could be obtained for fetal 
MSCs compared to adult ones in all conditions, and that the 
benefit of applying bioreactor culture over static culture was not 
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obvious for adult MSCs. Although the experiments with haMSCs 
were not as successful as with hfMSCs with respect to cell number 
and distribution, we believe that there is still the potential for a 
bioreactor system in a later stage of tissue culture with haMSCs. 
When static cultures lead to complete filling of the scaffold with 
closure of the pores, cells in the scaffold interior might undergo 
necrosis by mass transfer limitations. At that stage, a dynamic 
system, such as the biaxial rotating vessel presented in this 
study, might become favorable over static culture. Furthermore, 
in our study, the complex influence of rotational speed and 
medium perfusion speed on the fluid dynamics was not mod-
eled. Screening the influence of these parameters on MSC fate in 
additive manufactured scaffolds might result in optimal culture 
conditions in which a homogeneous distribution throughout the 
scaffold can be achieved without compromising cells viability or 
altering MSCs phenotype.
cOnclUsiOn
The biaxial rotating vessel bioreactor used in this study has shown 
to improve hfMSCs distribution and proliferation in 3D additive 
manufactured PEOT/PBT scaffolds. The hfMSCs in the biaxial 
bioreactor produced ECM while retaining a comparable gene 
expression profile as the basal levels of hfMSCs seeded statically 
in 2D. Static culture on 3D scaffolds with hfMSCs showed down-
regulation of f-actin, col-1, col-2, ALP, and runx2 gene expression 
levels and also resulted in less ECM production and lower cell 
numbers than in the biaxial bioreactor, thus suggesting a more 
quiescent state of hfMSCs. As a third well-known dynamic culture 
system, a perfusion bioreactor was introduced for the experiments 
with a more clinically relevant haMSCs population. No increase 
in cell number and cellular distribution upon culture in the biaxial 
or the perfusion bioreactor was observed for haMSCs, even after 
an extended period of static culture prior to culture in the biaxial 
bioreactors. In addition, the gene expression profile of haMSCs 
showed a different response to the culture in the biaxial bioreactor 
than the profile of hfMSCs. There were no consistent significant 
differences in cell number between 9 days of static culture and 
3 days of static culture followed by 6 days of bioreactor culture 
in both the biaxial bioreactor and the perfusion-flow bioreactor. 
Overall, the biaxial rotating vessel bioreactor introduced in this 
study has shown to maintain  hfMSCs viability and distribu-
tion throughout the scaffold, without inducing differentiation. 
Therefore, this system could serve as a tool to study cell activity 
in distinct 3D scaffolds.
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